Supporting Canadians with bone marrow failure diseases
The Aplastic Anemia & Myelodysplasia Association of Canada (AAMAC) is a leading funder of research into bone marrow failure diseases in Canada. Our volunteer-run organization supports patients and caregivers across the country who are living with aplastic anemia, myelodysplastic syndrome (also called MDS or myelodysplasia) and paroxysmal nocturnal hemoglobinuria (PNH).
Notice of Annual General Meeting
AGM held in Moncton, NB on Saturday, October 15, 2016 at 3pm (Atlantic Time)
Do you have MDS and are interested in participating in a clinical trial?
Please click to see if you qualify. If you feel that you qualify, please print the clinical trial information and discuss with your oncologist/hematologist.
Presently the trial is being conducted at: Juravinski Cancer Centre at Hamilton Health Sciences Centre, Princess Margaret Hospital and Odette Cancer Centre at Sunnybrook Hospital.
The Canadian Association of PNH Patients is holding a PNH patient and caregiver meeting in Montreal on September 24, 2016. See for details and registration: http://www.pnhca.org/news/invitation-montreal-patient-and-caregiver-meeting/
Clinical Trial Alert!
Kallisto Canada-wide clincial trial.
See "Treatment & Support" for details.
Patient Support Meetings 2016
See "Upcoming Events" for details